Haverford Trust Company’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.07M | Sell |
20,051
-7,464
| -27% | -$666K | 0.02% | 182 |
|
|
2026
Q1 | $1.98M | Sell |
27,515
-20,688
| -43% | -$1.59M | 0.02% | 177 |
|
|
2025
Q4 | $3.83M | Sell |
48,203
-776
| -2% | -$61.2K | 0.03% | 136 |
|
|
2025
Q3 | $3.69M | Sell |
48,979
-6,168
| -11% | -$423K | 0.03% | 138 |
|
|
2025
Q2 | $3.8M | Sell |
55,147
-21,667
| -28% | -$1.42M | 0.04% | 138 |
|
|
2025
Q1 | $5.2M | Sell |
76,814
-16,566
| -18% | -$991K | 0.05% | 116 |
|
|
2024
Q4 | $4.19M | Sell |
93,380
-7,698
| -8% | -$432K | 0.04% | 126 |
|
|
2024
Q3 | $6.36M | Sell |
101,078
-36,653
| -27% | -$2.14M | 0.06% | 112 |
|
|
2024
Q2 | $8.13M | Sell |
137,731
-1,449,304
| -91% | -$90.7M | 0.09% | 102 |
|
|
2024
Q1 | $127M | Sell |
1,587,035
-104,494
| -6% | -$7.98M | 1.32% | 26 |
|
|
2023
Q4 | $134M | Sell |
1,691,529
-111,789
| -6% | -$7.96M | 1.48% | 24 |
|
|
2023
Q3 | $126M | Sell |
1,803,318
-505,579
| -22% | -$35.8M | 1.53% | 21 |
|
|
2023
Q2 | $160M | Buy |
2,308,897
+3,213
| +0.1% | +$229K | 1.8% | 20 |
|
|
2023
Q1 | $171M | Buy |
2,305,684
+17,594
| +0.8% | +$1.48M | 2.05% | 17 |
|
|
2022
Q4 | $213M | Sell |
2,288,090
-14,599
| -0.6% | -$1.41M | 2.63% | 11 |
|
|
2022
Q3 | $220M | Sell |
2,302,689
-135,450
| -6% | -$13.4M | 3.01% | 5 |
|
|
2022
Q2 | $226M | Sell |
2,438,139
-2,959
| -0.1% | -$289K | 2.94% | 6 |
|
|
2022
Q1 | $247M | Sell |
2,441,098
-16,204
| -0.7% | -$1.7M | 2.85% | 5 |
|
|
2021
Q4 | $253M | Sell |
2,457,302
-5,203
| -0.2% | -$481K | 2.76% | 8 |
|
|
2021
Q3 | $209M | Sell |
2,462,505
-83,762
| -3% | -$7.02M | 2.5% | 10 |
|
|
2021
Q2 | $212M | Buy |
2,546,267
+35,692
| +1% | +$2.92M | 2.5% | 11 |
|
|
2021
Q1 | $189M | Buy |
2,510,575
+188,559
| +8% | +$13.7M | 2.42% | 11 |
|
|
2020
Q4 | $159M | Buy |
2,322,016
+28,895
| +1% | +$1.88M | 2.24% | 16 |
|
|
2020
Q3 | $134M | Sell |
2,293,121
-12
| -0% | -$747 | 2.14% | 17 |
|
|
2020
Q2 | $149M | Sell |
2,293,133
-33,680
| -1% | -$2.12M | 2.56% | 11 |
|
|
2020
Q1 | $138M | Buy |
2,326,813
+90,958
| +4% | +$6.07M | 2.8% | 9 |
|
|
2019
Q4 | $166M | Buy |
2,235,855
+4,281
| +0.2% | +$301K | 2.69% | 8 |
|
|
2019
Q3 | $141M | Buy |
2,231,574
+652,905
| +41% | +$38.7M | 2.47% | 12 |
|
|
2019
Q2 | $86M | Buy |
1,578,669
+46,182
| +3% | +$2.49M | 1.54% | 24 |
|
|
2019
Q1 | $82.6M | Buy |
1,532,487
+113,513
| +8% | +$7.01M | 1.53% | 25 |
|
|
2018
Q4 | $93M | Buy |
1,418,974
+75,605
| +6% | +$5.64M | 1.98% | 19 |
|
|
2018
Q3 | $106M | Buy |
1,343,369
+12,260
| +0.9% | +$877K | 1.95% | 18 |
|
|
2018
Q2 | $85.7M | Buy |
1,331,109
+300,852
| +29% | +$19.8M | 1.69% | 21 |
|
|
2018
Q1 | $64.1M | Buy |
1,030,257
+6,343
| +0.6% | +$455K | 1.28% | 30 |
|
|
2017
Q4 | $74.2M | Sell |
1,023,914
-20,607
| -2% | -$1.5M | 1.46% | 27 |
|
|
2017
Q3 | $84.9M | Sell |
1,044,521
-15,122
| -1% | -$1.2M | 1.77% | 22 |
|
|
2017
Q2 | $85.3M | Sell |
1,059,643
-4,114
| -0.4% | -$325K | 1.86% | 23 |
|
|
2017
Q1 | $83.5M | Sell |
1,063,757
-54,208
| -5% | -$4.33M | 1.91% | 23 |
|
|
2016
Q4 | $88.2M | Buy |
1,117,965
+37,735
| +3% | +$3.05M | 2.14% | 18 |
|
|
2016
Q3 | $96.1M | Buy |
1,080,230
+8,107
| +0.8% | +$765K | 2.4% | 12 |
|
|
2016
Q2 | $103M | Sell |
1,072,123
-2,418
| -0.2% | -$241K | 2.58% | 6 |
|
|
2016
Q1 | $111M | Buy |
1,074,541
+12,133
| +1% | +$1.18M | 2.9% | 2 |
|
|
2015
Q4 | $104M | Buy |
1,062,408
+19,846
| +2% | +$1.94M | 2.8% | 4 |
|
|
2015
Q3 | $101M | Sell |
1,042,562
-92,360
| -8% | -$9.71M | 2.92% | 3 |
|
|
2015
Q2 | $119M | Sell |
1,134,922
-5,683
| -0.5% | -$581K | 3.27% | 2 |
|
|
2015
Q1 | $118M | Sell |
1,140,605
-19,276
| -2% | -$1.95M | 3.26% | 2 |
|
|
2014
Q4 | $112M | Sell |
1,159,881
-25,660
| -2% | -$2.26M | 3.13% | 2 |
|
|
2014
Q3 | $94.4M | Sell |
1,185,541
-5,430
| -0.5% | -$428K | 2.82% | 3 |
|
|
2014
Q2 | $89.8M | Sell |
1,190,971
-11,455
| -1% | -$866K | 2.63% | 6 |
|
|
2014
Q1 | $90M | Sell |
1,202,426
-70,593
| -6% | -$4.99M | 2.78% | 7 |
|
|
2013
Q4 | $91.1M | Buy |
1,273,019
+7,621
| +0.6% | +$490K | 2.56% | 11 |
|
|
2013
Q3 | $71.8M | Buy |
1,265,398
+20,435
| +2% | +$1.22M | 2.61% | 17 |
|
|
2013
Q2 | $71.2M | Buy |
+1,244,963
| New | +$72.1M | 2.34% | 15 |
|
Other funds holding CVS
Haverford Trust Company's CVS Position: Q2 2026 in Review
Haverford Trust Company reduced its CVS Health (CVS) stake by 27% in Q2 2026, selling an estimated $666K and leaving 20,051 shares worth $2.07M. The position accounts for 0.02% of the portfolio, ranked #182.
Haverford Trust Company first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $253M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Haverford Trust Company held 20,051 shares of CVS Health worth $2.07M as of Q2 2026.
- Haverford Trust Company sold 7,464 CVS Health shares in Q2 2026, an estimated $666K.
- CVS Health made up 0.02% of Haverford Trust Company's portfolio in Q2 2026, its #182 holding.
- Haverford Trust Company first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- Haverford Trust Company's CVS Health position peaked at $253M in Q4 2021.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Haverford Trust Company's 13F filing for Q2 2026, filed 12 Aug 2026.